RxDoctor Payments Data

Jennifer Klock, DO

Family Medicine · Davison, MINPI 1801833975

Payments from drug & device makers

$803in general payments, 2019–2025

Across 58 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$218
  • Dexcom, Inc.$109
  • Supernus Pharmaceuticals, Inc.$94
  • AstraZeneca$72
  • GSK$42
  • Johnson & Johnson$40
  • plus $228 from 11 others

What the payments were for

  • Food & beverage$76495%
  • Education$395%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$803 in reported general payments places this provider in the 65th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$21,456
Medicare patients
61
Services billed
1,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab15$212,879
Humira(Cf) PenAdalimumab16$181,013
OzempicSemaglutide88$138,184
EliquisApixaban55$59,380
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$57,303
RybelsusSemaglutide19$39,439
XareltoRivaroxaban28$31,123
RexultiBrexpiprazole18$25,379
MounjaroTirzepatide16$21,889
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen426$7,815
Ventolin HfaAlbuterol Sulfate59$5,645
Lisdexamfetamine Dimesylate16$3,260
Atorvastatin Calcium169$3,074
Levothyroxine Sodium243$3,056
Albuterol Sulfate HfaAlbuterol Sulfate54$2,867

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$218$179,556118 claims
PfizerEliquis$40$59,38055 claims
GSKTrelegy Ellipta$42$57,30347 claims
Johnson & JohnsonXarelto$40$31,12328 claims
Lilly USA, LLCMounjaro$11$21,88916 claims
AbbVieArmour Thyroid$11$1,51912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Davison

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →